Search Results 101-110 of 19670 for Receptor

  1. A Study to Evaluate the Safety and Effectiveness of Capivasertib + Fulvestrant Versus Placebo + Fulvestrant as Treatment for Locally Advanced (Inoperable) or Metastatic Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Breast Cancer - Mayo Clinic

    ... Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Breast Cancer. Print details. Share; Facebook · Twitter. Overview ...

  2. Clinical trials - Oncology (Medical)

    ... receptor positive, estrogen receptor-positive, human epidermal growth receptor-2 negative metastatic breast cancer after progression on previous endocrine ...

  3. Liver Pathobiology Lab: Gregory J. Gores - Mayo Clinic Research

    Do death receptor cells promote TRAIL expression by macrophages? Are death receptor cells primed for cell death? Lab team member examining slide under a ...

  4. Diane F. Jelinek, Ph.D. - Mayo Clinic Faculty Profiles

    ... receptors, including the B cell antigen receptor, toll-like receptors, cytokine receptors and the receptor for CD40 ligand, a molecule expressed on T ...

  5. Projects - Liver Pathobiology Lab: Gregory J. Gores - Mayo Clinic Research

    Cholestatic liver injury · Does TRAIL or TRAIL receptor signaling limit the expansion of the death receptor (DR) cell population in cholestasis? · Do DR cells ...

  6. A Study Comparing 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR to Treat Patients with Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid Tumours - Mayo Clinic

    A Study Comparing 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR to Treat Patients with Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid ...

  7. Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast Cancer - Mayo Clinic

    ... receptors but not human epidermal growth factor receptor 2 (HER2) receptors on the surface of its cells. Estrogen can cause the growth of tumor cells ...

  8. A Safety and Effectiveness Study of Defibrotide in the Prevention of Chimeric Antigen Receptor-T-cell-associated Neurotoxicity - Mayo Clinic

    A Safety and Effectiveness Study of Defibrotide in the Prevention of Chimeric Antigen Receptor-T-cell-associated Neurotoxicity · Overview · Participation ...

  9. Impact of PAR1 on inflammation and recovery after spinal cord injury - Mayo Clinic

    Mayo Clinic researchers offer insight into the role of the thrombin receptor, also known as protease-activated receptor 1 (PAR1), and its impact on ...

  10. Valsartan (oral route) - Mayo Clinic

    Valsartan is an angiotensin II receptor blocker (ARB). It works by blocking a substance in the body that causes blood vessels to tighten. Valsartan relaxes ...